Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now

ShockWave Medical, Inc. (SWAV) is well poised for growth, backed by its research and development (R&D) efforts and focus on clinical studies.Shares of this currently Zacks Rank #2 (Buy) company have risen 37.3% compared with the industry’s 10.3% growth in the past year. The S&P 500 Index has soared 26.4% in the same time frame.With a market capitalization of $9.85 billion, this medical device company is committed to developing and commercializing products that can change the way calcified cardiovascular dis ...